SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 53 filers reported holding SUMMIT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $182,860 | +39.2% | 97,786 | +86.8% | 0.00% | – |
| Q2 2023 | $131,361 | -53.8% | 52,335 | -67.8% | 0.00% | – |
| Q1 2023 | $284,265 | +2654.8% | 162,437 | +6590.2% | 0.00% | – |
| Q4 2022 | $10,319 | -82.2% | 2,428 | -95.1% | 0.00% | – |
| Q3 2022 | $58,000 | -7.9% | 49,245 | -22.2% | 0.00% | – |
| Q2 2022 | $63,000 | -68.7% | 63,336 | -22.9% | 0.00% | – |
| Q1 2022 | $201,000 | -35.8% | 82,194 | -29.3% | 0.00% | – |
| Q4 2021 | $313,000 | -49.8% | 116,303 | -6.5% | 0.00% | – |
| Q3 2021 | $623,000 | -33.1% | 124,341 | -0.4% | 0.00% | – |
| Q2 2021 | $931,000 | +26.0% | 124,794 | -0.9% | 0.00% | – |
| Q1 2021 | $739,000 | +13.7% | 125,973 | -8.9% | 0.00% | – |
| Q4 2020 | $650,000 | +34.0% | 138,287 | -1.9% | 0.00% | – |
| Q3 2020 | $485,000 | – | 140,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 202,928 | $862 | 0.29% |
| AWM Investment Company, Inc. | 300,000 | $1,275,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,835 | $182,049 | 0.10% |
| Baker Brothers Advisors | 2,000,000 | $8,500,000 | 0.05% |
| VANCE WEALTH, INC. | 13,299 | $56,521 | 0.04% |
| Inscription Capital, LLC | 17,000 | $72,250 | 0.02% |
| Steward Partners Investment Advisory, LLC | 305,000 | $1,296,250 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 221,205 | $940,121 | 0.02% |
| LEVIN CAPITAL STRATEGIES, L.P. | 39,176 | $166,498 | 0.02% |
| 683 Capital Management, LLC | 50,838 | $216,062 | 0.02% |